The co-transfer of Treg-of-B cells with CD4+CD45RBhi effector T cells into SCID mice effectively inhibited the symptoms of colitis and reduced the production of Th1 and Th17 cytokines in the MLNs and colons (Figs 2 and 3). The gene discussed is CD4; the disease is colitis.